• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA issues Class I recall for Hamilton Medical ventilator components

FDA issues Class I recall for Hamilton Medical ventilator components

August 12, 2026 By Skyler Rivera

A photo of a recalled Hamilton Medical's coaxial breathing circuit set
Hamilton Medical’s coaxial breathing circuit set (PN: 260128) used with Hamilton-C1 and T1 ventilators is one of the affected sets in the recall. [Photo courtesy of Hamilton Medical]
The FDA issued a Class 1 recall for certain Hamilton Medical coaxial breathing circuit sets after reports of four serious injuries.

Hamilton Medical said certain lots of coaxial breathing circuit sets used with its Hamilton-C1, Hamilton T-1 and Hamilton-MR-1 ventilators are preassembled with an expiratory valve set that doesn’t perform as intended.

“In some cases, the expiratory valve membrane adhered to the sealing ring on the body of the expiratory valve, impairing valve opening and expiratory gas flow,” the company said in the recall. “The issue is not detected during the pre-operative test of the ventilator unless a test lung is actively ventilated.”

If the expiratory valve is stuck to the sealing ring, the malfunction appears within the patient’s first breaths after ventilation.

When expiratory gas flow is impeded, end-expiratory pressure rises or end-expiratory flow drops, triggering the ventilator’s “Exhalation Obstructed” alarm. The obstruction of expiratory flow causes inadequate ventilation and impaired gas exchange, which may result in poor ventilation and oxygen desaturation (hypoxemia), the recall said.

Related: BD recalls vascular access system needles after 4 patient deaths

A Class I recall is the most serious type of FDA recall, in which use of the device without correction may cause serious injuries or death. As of July 2, 2026, Hamilton Medical has reported four serious injuries and no deaths associated with the issue.

Hamilton Medical sent a letter to customers in May recommending that the breathing circuit sets be removed from where they’re used or sold.

MassDevice reached out to Hamilton Medical for comment and did not receive a response by the time of publication. We will update the story as necessary.

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Hamilton Medical, recall

More recent news

  • Retired Stryker leader Tim Scannell dies at 62
  • HighLife raises more than $90M to advance its TMVR system
  • UltraSight raises $24M in Series B2 to scale AI-guided cardiac ultrasound technology
  • Convatec launches new hydrophilic option for self-catheterization
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact

About Skyler Rivera

Skyler Rivera is an associate editor at Arrowfly, covering medical device industry news and technology at MassDevice and Medical Design & Outsourcing. She began her career covering sports at The Athletic and MLB before transitioning to medical writing at Edwards Lifesciences. Based in Southern California, she holds a master's degree in science writing from Johns Hopkins University and a bachelor’s in broadcast journalism from Syracuse University. Connect with her on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy